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Background: There is growing evidence that endothelial failure and subsequent blood brain barrier (BBB)
breakdown initiate cerebral small vessel disease (CSVD) pathology. In spontaneously hypertensive stroke-prone rats
(SHRSP) endothelial damage is indicated by intraluminal accumulations of erythrocytes (erythrocyte thrombi) that
are not observed with current magnetic resonance imaging techniques. Two-photon microscopy (2 PM) offers the
potential for real-time direct detection of the small vasculature. Thus, within this pilot study we investigated the
sensitivity of 2 PM to detect erythrocyte thrombi expressing initiating CSVD phenomena in vivo.
Methods: Eight SHRSP and 13 Wistar controls were used for in vivo imaging and subsequent histology with
haematoxylin-eosin (HE). For 2 PM, cerebral blood vessels were labeled by fluorescent Dextran (70 kDa) applied
intraorbitally. The correlation between vascular erythrocyte thrombi observed by 2 PM and HE-staining was
assessed. Artificial surgical damage and parenchymal Dextran distribution were analyzed postmortem.
Results: Dextran was distributed within the small vessel walls and co-localized with IgG.
Artificial surgical damage was comparable between SHRSP and Wistar controls and mainly affected the small
vasculature. In fewer than 20% of animals there was correlation between erythrocyte thrombi as observed with
2 PM and histologically with HE.
Conclusions: Contrary to our initial expectations, there was little agreement between intravital 2 PM imaging and
histology for the detection of erythrocyte thrombi. Two-photon microscopy is a valuable technique that
complements but does not replace the value of conventional histology.
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Human cerebral small vessel disease (CSVD) is commonly
found in the brains of the elderly and in Alzheimer’s dis-
ease (AD) as demonstrated in autopsy and human imaging
studies [1-8]. CSVD affects the capillaries and small arter-
ies and is initiated by an early endothelial damage with
subsequent blood brain barrier (BBB) breakdown [9-15].
Current human magnetic resonance imaging (MRI) tech-
niques fail to directly detect the initial stages of the patho-
logical process and instead identify advanced CSVD
features including white matter hyperintensities (WMH),
microbleeds, recent subcortical infarcts and lacunes* Correspondence: Solveig.niklass@med.ovgu.de
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stated.already associated with cognitive decline [11,16-18]. The
development of efficient prophylactic and early thera-
peutic strategies for CSVD requires the establishment of
biomarkers indicative of the early endothelial failure that
are identifiable by imaging.
Spontaneously hypertensive stroke-prone rats (SHRSP)
develop all features of human CSVD including an endo-
thelial dysfunction with resulting BBB damage indicated
by plasma protein leakage into the small vessel walls and
the perivascular parenchyma [13]. Subsequent small ves-
sel wall thickening occurs and increasing fragility of the
vasculature leads to perivascular bleeds, reactive micro-
thromboses and associated tissue infarcts [12,19].
The early endothelial damage in SHRSP results in
an activated coagulatory state followed by the forma-
tion of an intravasal mesh of thrombocytes and theLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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erythrocytes adhere and aggregate and, thus, become visible
as erythrocyte thrombi by the conventional histology [12].
Therefore, erythrocyte thrombi could serve as the sought
biomarker indicative of initiating CSVD pathologies.
Indeed, first pilot 3Tesla (T) and 4.7 T MRI studies failed
to visualize those erythrocyte thrombi; more recently, high
field MRI experiments have been undertaken [12,20].
The main advantages of two-photon microscopy (2 PM),
an additional intravital imaging technique, include its po-
tential for the direct visualization of the small, cortical,
vasculature including capillaries and arterioles, with the dis-
advantage associated with the invasive nature of the tech-
nique [21-23]. Intravital microscopy is performed using
fluorescent labeled Dextran to visualize cerebral vessels and
thus, blood flow can be determined by velocity measure-
ments of erythrocytes, which are directly visible within the
small vasculature [22-29].
The 2 PM has been established in different rat models
including Wistar and Sprague Dawley rats without in-
trinsic cerebrovascular pathologies [23,30,31] and spon-
taneously hypertensive rats (SHR), an animal model of
chronic arterial hypertension with a rather low inci-
dence of spontaneous infarct development [13,32]. SHR
and SHRSP both develop arterial hypertension and an
associated vascular pathology; however, the pathology is
more severe in SHRSP [33]. Within this first pilot study
we aimed to investigate whether 2 PM could be per-
formed safely in SHRSP, an appropriate model of CSVD
pathology, with consecutive high spontaneous infarct
frequencies. We analyzed the vulnerability to artificial
surgical damage. Furthermore, we investigated the sen-
sitivity of 2 PM to detect erythrocyte thrombi. Our hy-
pothesis was that intravital 2 PM is suitable for the
direct visualization of intravasal erythrocyte clusters.
Combining MRI and 2 PM approaches could therefore
provide new insights into the establishment of bio-
markers indicative of early CSVD pathology.
Materials and methods
Animals
All experiments were approved by the local Animal Care
Committee of Saxony-Anhalt (42502-2-1148 DZNE). Fif-
teen male SHRSP (Charles River Laboratories International
Inc., Wilmington, MA, USA) aged from 30 to 32 weeks (w)
and 15 male Wistar rats (Charles River Laboratories Inter-
national Inc., Wilmington, MA, USA) at different age
groups (17-21 w - n = 4, 27-29 w - n = 3, 30-32 w - n = 4,
33-36 w - n = 4) were investigated. Eight SHRSP were used
for in vivo two-photon imaging and 7 SHRSP underwent
sole in vivo Dextran application without intravital imaging
to investigate the Dextran distribution within the tissue.
Age groups were chosen because of the high likelihood to
detect erythrocyte thrombi in 30 to 32 w old SHRSP. Aspreviously demonstrated, we expected the young Wistar
controls to be free of erythrocyte thrombi and therefore
serving as an excellent control group [12]. All animals were
housed with a natural light-dark cycle and allowed to access
water and food ad libitum.
Two-photon imaging
A. Anesthesia and cranial window preparation
All rats were anesthetized by intraperitoneal injections
of Pentobarbital (1 mL per 100 g body weight); depth of
anesthesia was tested by the absence of reflections after
a painful stimulus. During surgery the body temperature
was maintained at 37°C with a thermostatically con-
trolled warming pad (Harvard Apparatus, March, GER).
After shaving the skull and its fixation in a stereotactic
frame (Stoelting Europe, Dublin, IRL), the scalp was lifted
with a forceps (Fine Science Tools (FST), Heidelberg,
GER) and opened by surgical scissors (FST, Heidelberg,
GER). Within the surgical area the periosteum was re-
moved from the surface of the skull with a sharp double-
spoon (sharp spoon after Willinger; Intermedical24,
Regensburg, GER) over the surgical area. Bleeding vessels
were closed with a cautery kit (Bovie Medical, Clearwater,
USA) and the skull was cleaned and disinfected with a 3%
H2O2 solution (Carl Roth, Karlsruhe, GER). Under a surgi-
cal microscope (Carl Zeiss Meditec, Oberkochen, GER)
the skull was thinned with a Dremel (Dremel Europe,
Konijnenberg NL) and a drill (Eickemeyer, Tuttlingen,
GER) was used to prepare the cranial window over the
parietal cortex located between -2 mm and -6 mm in rela-
tion to the Bregma and 1 mm to 5 mm lateral in relation
to the sagittal suture. The skull was regularly cleaned with
compressed air (CRC Industries UK Ltd, Bridgwater, UK)
to avoid soiling of the field in which surgery was con-
ducted. After removing the bone piece carefully, a small
syringe needle (B. Braun, Melsungen, GER) was used to
make a little incision and remove the dura mater to the
edge of the cranial window by using a spring scissor (FST,
Heidelberg, GER). In mice, intravital imaging is usually
performed throughout the intact dura mater [29], thus,
an additional preparation without removing the dura
mater was attempted in two of the 15 Wistar rats, too.
After surgery the cranial window was filled with sterile ir-
rigation (e.g. sodium chloride 0,9%; B. Braun, Melsungen,
GER) and sealed by a 7 mm cover glass (Gerhard Menzel,
Braunschweig, GER) using the instant glue Roti-coll 1
(Carl Roth, Karlsruhe, GER).
B. In vivo imaging
After surgery, in vivo imaging was performed with the
LSM 7 MP multiphoton microscope (Carl Zeiss Micros-
copy, Oberkochen, GER) using the Chameleon Vision 2
laser (Coherent Inc., Santa Clara, CA, USA). To image
cerebral blood vessels, the blood plasma was marked by
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Life Technologies, Darmstadt, GER), applied intraorbitally
with a small syringe (B. Braun, Melsungen, GER). For im-
aging, the skull of the rats was fixed in a head holder
(Luigs und Neumann, Ratingen, GER) and the animals
were placed on a heating plate (Physitemp Instruments,
Clifton, NJ, USA) under the microscope for one imaging
session. The known maximum achievable depth for
in vivo imaging in rats is up to 500 μm [34,35], confirmed
by our measurements covering all cortical layers with
maximal imaging depths of 300 μm to 500 μm.
Perfusion
All animals were transcardially perfused directly after im-
aging with 120 mL phosphate-buffered saline (PBS)
followed by fixation through perfusion with 120 mL of 4%
paraformaldehyde (PFA) within 8 minutes. After decapita-
tion, the brains were removed, fixed in 4% PFA for 48
hours, placed into 30% sucrose for cryo-protection for 6
days, and frozen in methylbutane (Carl Roth, Karlsruhe,
GER) at -80°C.
Histology
Twenty-four hours before coronal slices (30 μm) were pre-
pared the brains were stored at-20°C. The whole brains of
all animals were sliced from the frontal to the occipital
pole using a cryotoma (Leica Biosystems, Nussloch, GER).
Per animal there were 10 sectional planes with a distance
of 930 μm between the frontal pole and the first sectional
plane and a distance of 1 mm between each sectional
plane respectively. Of each sectional plane three slices per
brain and therefore 30 slices per rat were stained with
Haematoxylin-Eosin (HE). The surgical area was located
between the 5th and the 9th sectional plane, thus, the dis-
tances between the frontal pole and the surgical area were
about 5 mm to 9 mm respectively and thus, the surgical
area covered about 4 mm of the brain. Of the 5 sectional
planes covering the surgical area, 15 slices per animal were
available for histological analysis. In brief, HE-staining was
performed as follows: slices were washed with distilled
water, immersed in Haemalaun solution after Mayer (Carl
Roth, Karlsruhe, GER) for 5 minutes, washed again,
blued under running tap water for 10 minutes and
stained with Eosin (Carl Roth, Karlsruhe, GER) for 40
seconds. Dehydration of the slices by immersion in in-
creasing concentrations of alcohol (Rotisol; Carl Roth,
Karlsruhe, GER) and in Xylene (Carl Roth, Karlsruhe,
GER) was followed by mounting with Histomount
(Shandon Histomount™ Xylene Substitute Mountant;
Fisher Scientific, Schwerte, GER).
Immunohistochemistry
Brain slices of 9 SHRSP (3 with 2 PM, 6 with sole Dextran
application without intravital imaging, 4-5 slices peranimal) and 1 Wistar rat (with 2 PM, 4 slices) were inves-
tigated immunohistochemically. Slices were adjacent to
the slices used for HE-staining. In short, repeated washing
of the slices in PBS and blocking with 0.1 mol/L PBS, 0.5%
Triton-X (Carl Roth, Karlsruhe, GER) and 10% donkey
serum (Sigma-Aldrich, St Louis, MO, USA) was followed
by immunohistochemical staining with solanum tubero-
sum lectin-fluorescein isothiocyanate (STL-FITC, endo-
thelial marker [36], 1:500; Axxora, Enzo Life Sciences
GmBH, Lörrach, GER) overnight at 4°C in PBS containing
5% donkey serum. Slices were washed anew before appli-
cation of Cy5-donkey anti-rat Immunglobulin G (IgG,
1:200; Jackson ImmunoResearch, West Grove, PA,
USA) for 2 hours at room temperature. Cy5-donkey
anti-rat IgG was used for detection of BBB breakdown
[36]. Finally DAPI staining (DAPI = 4′.6-Diamidin-2-
phenylindol, 1:10000; MoBiTec, Göttingen, GER) was
performed for 20 minutes at room temperature. In vivo
applied Dextran (Dextran, Tetramethylrhodamine; Life
Technologies, Darmstadt, GER) was visualized post
mortem by Tetramethylrhodamine labeling. After dehy-
dration with increasing concentrations of alcohol, slices
were mounted on slides with Histomount.
Quantification and statistics
The surgical area was investigated histologically in all
SHRSP and Wistar control rats to detect artificial damage
(infarcts, hemorrhages, small bleeds, partial thromboses)
caused by surgery. Additionally, all capillaries and arteri-
oles in the surgical area were examined for the occurrence
of erythrocyte thrombi within 2 PM and HE-stained slices.
Quantification was performed in a binary manner (exist-
ent, not existent), respectively. For all parameters (artificial
damage, erythrocyte thrombi) student’s t-test was used to
calculate the differences between the controls and SHRSP
group. P-values ≤0.05 were deemed to be statistically
significant.
Results
Surgery and imaging
Surgery and anesthesia were well tolerated by both rat
groups. None of the animals died during the imaging ses-
sions. In two control animals imaging was not successful
so they were not investigated histologically. The cerebral
blood vessels, including small arteries, arterioles and the
capillary bed, could be visualized well and reproducibly by
2 PM (Figure 1A). In addition to vessels without patho-
logical features (Figure 1B), leakage of the contrast agent
out of the small vessel walls histologically confirmed as
bleeding (Figure 1C) was detected and black dotted intra-
vasal and wall adherent contrast agent gaps were sus-
pected erythrocyte thrombi (Figure 1D and E). Additional
features of erythrocyte thrombi suspected in the 2 PM in-
cluded no or slow movements of the “contrast agent gaps”.
Figure 1 Two-photon microscopy of small cortical vessels. In vivo imaging of SHRSP and Wistar control rats revealed the excellent
detectability of arterioles and the capillary bed (A, SHRSP, 30 w). Non pathological vessels (B, Wistar, 31 w) and arteriolar Dextran leakage
indicative for vessel wall damage with suspected perivascular bleeds (C, SHRSP, 31 w) were detected. D (SHRSP, 31 w) shows a capillary with
suspected erythrocyte thrombi indicated by not moving dark spots (local gaps of Dextran contrast agent, white arrows), E (SHRSP, 30 w) displays
the accumulation of Dextran in an arteriole (white arrow). The arrowhead in F (Wistar, 36 w) marks a rather plane lack of contrast agent in the
vessel wall possibly indicative of endothelial injuries. w – age in weeks, scale bars = 50 μm.
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wall (Figure 1F, white arrowhead) might be interpreted as
endothelial injury.
In the two Wistar rats without dura mater removal, pre-
dominantly the blood vessels of the intact dura mater were
visible. The depth for imaging of cortical vessels was thus
restricted to about 70 μm (1st cortical layer [37]) instead of
about 500 μm (3rd cortical layer [37]) in the remaining ani-
mals with dura mater removal. Moreover in both Wistar
rats without dura mater removal the blood vessels of theFigure 2 HE-staining of the surgical area in SHRSP and controls with
control rats (D, 30-32 w) and artificial damage in both groups (B and C, SHRS
Wistar (D) show surgical fields that are free of any artificial vascular damage, b
and small artificial bleeds (C, SHRSP; F, Wistar control). w – age in weeks, scaledura mater blasted through repeated laser illumination, so
no further recording was possible.
Artificial vascular damage
SHRSP (Figure 2A-C) and Wistar control rats (Figure 2D-F)
showed no histological differences in the surgical area
(Figure 3). In both groups there were surgical fields
without any artificial vascular damage (Figure 2A,D).
Artificial damage in the surgery area included the detec-
tion of densely packed erythrocytes within capillaries,dura removal. The surgical area of SHRSP (A, 30-32 w) and Wistar
P; E and F, Wistar controls) cannot be distinguished. Both, SHRSP (A) and
ut also areas with partial capillary thromboses (B, SHRSP; E, Wistar control)
bars = 100 μm.
Figure 3 Histogram of artificial vascular damage through
surgery with dura removal. Prevalence of artificial vascular damage
through surgery including partial capillary thromboses and small
bleeds was comparable between SHRSP and Wistar control rats.
Table 1 Erythrocyte thrombi (stases) in the surgical field
of SHRSP suspected by 2 PM and confirmed histologically
SHRSP HE-staining (confirmed) 2 PM (suspected)
Age animals Capillary
stases
Arteriolar
stases
Capillary
stases
Arteriolar
stases
30 w 701 1 1 0 0
711 1 0 0 1
31 w 623 1 1 0 0
712* 1 1 1 1
713 1 0 0 0
714 1 0 0 1
32 w 620 1 0 0 0
621 1 0 0 0
Total number 8 3 1 3
in% 100% 38% 13% 38%
HE-investigations of SHRSP revealed the affection of all animals (100%) by
capillary erythrocyte thrombi, whereas 2 PM failed to confirm those capillary
erythrocyte aggregations in most of the rats. Only three SHRSP showed
arteriolar erythrocyte thrombi that could be detected intravitally in only one of
those rats (SHRSP 712). Only in SHRSP 712 (asterisk) imaging and histological
data were matched well. Within the remaining SHRSP results obtained from
histology and intravital microscopy completely differed.
1 – existent, 0 – not existent.
Table 2 Erythrocyte thrombi (stases) in the surgical field of
Wistar rats suspected by 2 PM and confirmed histologically
Wistar HE-staining (confirmed) 2 PM (suspected)
Age animals Capillary
stases
Arteriolar
stases
Capillary
stases
Arteriolar
stases
17 w 47 0 0 0 0
20 w 48 0 0 0 0
49 0 0 0 0
27 w 52** 0 0 0 0
29 w 55** 0 0 0 0
30 w 89 0 0 0 0
31 w 60 1 1 0 0
90 0 0 1 0
32 w 57 0 0 1 0
33 w 62 0 0 0 0
34 w 59 0 1 0 0
35 w 64 1 0 0 0
36 w 65 1 1 0 0
Total number 3 3 2 0
in% 23% 23% 15% 0%
HE-investigations of Wistar control rats revealed erythrocyte thrombi within
the capillaries (n = 3 animals, 23%) and arterioles (n = 3 animals, 23%). With
intravital imaging in some animals capillary (n = 2, 15%) but no arteriolar
erythrocyte accumulations were suspected. Overall, results obtained from both
techniques did not fit in any of the controls.
1 – existent, 0 – not existent; ** – animals without dura mater removal.
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boses, Figure 2B,E) and small bleeds (Figure 2C,F).
Thrombi likely hampered the Dextran to flow through
the plugged capillaries and thus, were not visible with
2 PM imaging. Contrary, “normal” capillary erythrocyte
thrombi indicative of endothelial and BBB failure (initi-
ating phenomena of CSVD pathology in SHRSP, [12])
were characterized by intravasal erythrocytes which
were commonly well distinguishable from each other and
regularly preserving their shapes (see [12,14]). Thus,
erythrocyte thrombi and artificial partial thromboses could
be clearly distinguished. Both artificial phenomena, partial
capillary thromboses and small bleeds, occurred with
equal frequencies within the SHRSP and the control group
(Figure 3). Severity of artificial damage in terms of the fre-
quency of capillary thromboses and small bleeds per af-
fected animal did not differ between the groups
(thromboses: p = 0.078; small bleeds: p = 0.206). None of
the rats developed any tissue infarctions or large paren-
chymal hemorrhages within the surgical field.
Detection of intravasal erythrocyte thrombi
In conventional histology performed after intravital im-
aging, the prevalence of erythrocyte accumulations in
terms of erythrocyte thrombi was 100% within the surgical
field of SHRSP (Table 1). Thereby, the capillary bed was
affected in total (100%), whereas the arterioles in only
three (38%) SHRSP (Table 1). In contrast, fewer Wistar
control animals exhibited erythrocyte thrombi within the
capillaries (n = 3, 23%) and arterioles (n = 3, 23%, Table 2).
Histological prevalence of intravasal erythrocyte thrombi
was significantly higher in the SHRSP group compared to
the controls (p = 0.005), a result in line with our previous
work [12]. Contrary, according to our definitions of intra-
vital erythrocyte thrombi appearance (see Results, part
Surgery and Imaging) 2 PM assumed capillary erythrocyte
Figure 4 Detection of intravasal erythrocyte thrombi. In vivo imaging was performed before brain slices were investigated by HE-staining.
Comparison of the results independently revealed from both techniques showed quite well matched data in only one animal (SHRSP 712, Table 1).
Here, the intravitally suspected arteriolar (B, white arrow) and capillary (B, white arrowhead) erythrocyte thrombi match those found histologically
(A, inlay shows an exemplary arteriolar erythrocyte thrombus). In contrast, data of SHRSP 711 (Table 1) represent exemplary results indicative of
the mismatch between imaging and histological data found in the remaining animals. Here, arteriolar erythrocyte thrombi were suspected with
2 PM (D, white arrow), but no arteriolar erythrocyte thrombi were found within the whole surgical area (C). w – age in weeks, scale bars = 50 μm.
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rats (15%, Table 2), and arteriolar erythrocyte thrombi in
three SHRSP (38%, Table 1) and none of the controls
(Table 2).
The occurrence of erythrocyte thrombi suspected with
intravital imaging and confirmed histologically was thus
only 17% for arteriolar erythrocyte thrombi (in 1 out of 6
animals, Tables 1 and 2) and even lower for capillary
erythrocyte thrombi (9%, in 1 out of 11 animals, Tables 1
and 2). For example, images from animal SHRSP 712, theFigure 5 Distribution of Dextran and demonstration of endothelial le
under in vivo conditions and visualized by Rhodamin post mortem. A show
B perivascular deposits are detected (white arrow). Note the co-localization
by Dextran. A – corpus callosum, B, C – cortex; STL – solanum tuberosumonly animal with histological and in vivo similar set of data
in agreement with each other (Table 1, asterisk), are
shown in Figure 4A and B. Data of SHRSP 711 as an ex-
ample demonstrate the non-concordance of imaging and
histological results regarding the detection of erythrocyte
thrombi (Figure 4C and D).
Dispersal of dextran
In vivo applied Dextran was labeled with Rhodamin and
thereby visualized post mortem. Dextran could beaks. Dextran (70 kDa) was applied in 30-32 weeks old SHRSP (A-D)
s vessel wall adherent accumulations of Dextran (white arrow), in
of IgG and Dextran in C indicating the detection of BBB breakdown
lectin, IgG – Immunglobulin G, DAPI – 4′.6-Diamidin-2-phenylindol.
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accumulations to the vessel wall (Figure 5A, white arrow)
and perivascular deposits (Figure 5B, white arrow). Dextran
was co-localized with IgG (Figure 5C) indicating its capabil-
ity for BBB breakdown detection.
Discussion
Within the present pilot imaging study of SHRSP and
Wistar controls we investigated the safety of 2 PM refer-
ring to the artificial surgical damage considered firstly
against the background of small vessel vulnerability of
SHRSP and secondly the sensitivity of this method to
detect erythrocyte thrombi indicative of early CSVD
stages. We demonstrated that artificial damage was com-
parable between both rat groups and mainly included
the development of partial capillary thromboses and
small bleeds. Indeed, most likely due to the short time
span between the imaging procedure and the perfusion
process with subsequent histological examination of the
brains, no associated infarcts or large parenchymal hem-
orrhages developed. Contrary to our initial hypothesis, ac-
cordance between imaging of erythrocyte thrombi in
2 PM and confirmation of erythrocyte thrombi in HE was
rather poor. Intravitally applied Dextran used for 2 PM
small vessel visualization served as excellent marker for
BBB breakdown detection. Further studies will focus on
concurrent markers indicative of the endothelial dysfunc-
tion e.g. on the investigation of the accordance between
intravital and postmortem Dextran accumulations associ-
ated with the vascular walls. We are currently performing
intravital measurements of the cerebral blood flow (CBF)
in small vessels, aiming to identify areas of hypoperfusion
that may be associated with CSVD.
To the best of our knowledge, the nature and frequency
of artificial surgical damage have not been reported in de-
tail in mice or in rats following the removal of dura mater
[21,23,25,26,30-32,38-41]. Thus, we cannot discuss our
findings in relation to the data of other research groups.
Indeed, artificial damage exclusively affected the small vas-
culature and resulted in insignificant fatalities. Thereby,
dura mater removal with subsequent damage of cortical
small vessels appeared to be the main source for the de-
tected surgical injury. However, dura mater removal is im-
plicitly necessary for imaging of parenchymal vessels in
the rat brain [21,29,32,35,41] and thus, the hazard associ-
ated with the surgical damage is not related to the rat
model used in experiments, with or without intrinsic vas-
cular pathologies.
From our current point of view there are no convincing
reasons that could provide a complete explanation of the
low incidence of detection of erythrocyte thrombi with in-
travital imaging and histology. The possible causes could
be attributed to the limitations of the methods employed.
For example, the intravital definition of erythrocytethrombi might not have been sufficient and the complete
definition should include other phenomena; our chosen
definitions for this study were in line with those of other
groups [42]. Only few SHRSP and Wistar controls exhibited
arteriolar erythrocyte thrombi, which should be more sensi-
tive to detection with 2 PM compared to the erythrocyte
thrombi in the capillary bed. As there is an age-dependent
progressive spread of erythrocyte thrombi from the capillar-
ies into the arterioles and small arteries, future studies
should include older animals [12]. Moreover, extending the
investigations to a higher number of animals and addition-
ally increasing the 2 PM recordings per animal may also
lead to a better agreement of imaging and histology data.
To our best knowledge, there is no current work provid-
ing details on parenchymal Dextran distribution in rats
[21,23,25,30-32,41]. Here we showed for the first time that
Dextran (70 kDa) accumulated within the walls of small
vessels. It is therefore potentially comparable to Evans
Blue [43-45] and thus could be used for in vivo detection
of damage to the BBB. Compared to IgG, Fibrinogen and
Fibronectin, the conventional markers of BBB breakdown,
Dextran may yield more results by revealing even
smaller endothelial leaks because of its comparably
lower molecular weight (IgG 150 kDa [46], Fibrinogen
300 kDa [47], Fibronectin 440 kDa [48]). Lower molecu-
lar weight Dextrans (e.g. 4 kDa, 40 kDa) may be even
more promising markers for minor endothelial injuries.
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